🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
1.950
-0.180 (-8.45%)
Nov 20, 2026, 4:00 PM EST - Market closed

AC Immune Statistics

Total Valuation

AC Immune has a market cap or net worth of $193.88 million. The enterprise value is $109.97 million.

Market Cap193.88M
Enterprise Value 109.97M

Important Dates

The last earnings date was Wednesday, November 4, 2026, before market open.

Earnings Date Nov 4, 2026
Ex-Dividend Date n/a

Share Statistics

AC Immune has 99.43 million shares outstanding. The number of shares has increased by 2.58% in one year.

Current Share Class 99.43M
Shares Outstanding 99.43M
Shares Change (YoY) +2.58%
Shares Change (QoQ) -36.05%
Owned by Insiders (%) 5.71%
Owned by Institutions (%) 4.43%
Float 39.18M

Valuation Ratios

PE Ratio n/a
Forward PE 17.17
PS Ratio 8.16
Forward PS 22.00
PB Ratio 4.06
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 4.63
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.14.

Current Ratio 0.85
Quick Ratio 0.80
Debt / Equity 0.14
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -166.53

Financial Efficiency

Return on equity (ROE) is -80.66% and return on invested capital (ROIC) is -48.24%.

Return on Equity (ROE) -80.66%
Return on Assets (ROA) -23.20%
Return on Invested Capital (ROIC) -48.24%
Return on Capital Employed (ROCE) -90.99%
Weighted Average Cost of Capital (WACC) 12.93%
Revenue Per Employee $194,657
Profits Per Employee -$354,172
Employee Count122
Asset Turnover 0.13
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -37.50% in the last 52 weeks. The beta is 1.61, so AC Immune's price volatility has been higher than the market average.

Beta (5Y) 1.61
52-Week Price Change -37.50%
50-Day Moving Average 2.43
200-Day Moving Average 2.63
Relative Strength Index (RSI) 36.00
Average Volume (20 Days) 242,944

Short Selling Information

The latest short interest is 2.95 million, so 6.34% of the outstanding shares have been sold short.

Short Interest 2.95M
Short Previous Month 3.26M
Short % of Shares Out 6.34%
Short % of Float n/a
Short Ratio (days to cover) 14.73

Income Statement

In the last 12 months, AC Immune had revenue of $23.75 million and -$43.21 million in losses. Loss per share was -$0.42.

Revenue23.75M
Gross Profit -27.43M
Operating Income -45.31M
Pretax Income -43.21M
Net Income -43.21M
EBITDA -43.66M
EBIT -45.31M
Loss Per Share -$0.42
Full Income Statement

Balance Sheet

The company has $88.59 million in cash and $4.67 million in debt, with a net cash position of $83.92 million or $0.84 per share.

Cash & Cash Equivalents 88.59M
Total Debt 4.67M
Net Cash 83.92M
Net Cash Per Share $0.84
Equity (Book Value) 32.29M
Book Value Per Share 0.48
Working Capital -18.05M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$60.08 million and capital expenditures -$706,770, giving a free cash flow of -$60.79 million.

Operating Cash Flow -60.08M
Capital Expenditures -706,770
Depreciation & Amortization 1.63M
Net Borrowing -1.14M
Free Cash Flow -60.79M
FCF Per Share -$0.61
Full Cash Flow Statement

Margins

Gross margin is -115.49%, with operating and profit margins of -190.79% and -181.95%.

Gross Margin -115.49%
Operating Margin -190.79%
Pretax Margin -181.95%
Profit Margin -181.95%
EBITDA Margin -183.86%
EBIT Margin -190.79%
FCF Margin n/a

Dividends & Yields

AC Immune does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -2.58%
Shareholder Yield -2.58%
Earnings Yield -21.50%
FCF Yield -31.35%

Analyst Forecast

The average price target for AC Immune is $8.36, which is 328.82% higher than the current price. The consensus rating is "Strong Buy".

Price Target $8.36
Price Target Difference 328.82%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (3Y) 211.24%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

AC Immune has an Altman Z-Score of -4.29 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.29
Piotroski F-Score 2